Sotalol 120mg Tablets

Manufacturer APOTEX USA Active Ingredient Sotalol Tablets(SOE ta lole) Pronunciation SOE ta lole
WARNING: This drug may cause a life-threatening type of heartbeat that is not normal (prolonged QT interval). Talk with your doctor if you have a long QT on ECG.You will have to start and restart this drug in a setting where your heart will be watched nonstop. Talk with your doctor.If you have kidney disease, talk to your doctor. @ COMMON USES: It is used to treat certain types of life-threatening abnormal heartbeats.It is used to keep a normal heartbeat in people who have a certain type of abnormal heartbeat (atrial fibrillation or atrial flutter).
đŸˇī¸
Drug Class
Antiarrhythmic
đŸ§Ŧ
Pharmacologic Class
Beta-adrenergic Blocker; Potassium Channel Blocker
🤰
Pregnancy Category
Category C
✅
FDA Approved
Oct 1992
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Sotalol is a medication used to treat certain types of irregular heartbeats (arrhythmias). It works by slowing down the heart rate and helping the heart beat more regularly. It's important to take this medication exactly as prescribed and to be aware of potential side effects, especially a serious type of irregular heartbeat called Torsade de Pointes.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow these instructions carefully:

Take your medication exactly as directed by your doctor. Read all the information provided to you and follow the instructions closely.
You can take this medication with or without food.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.
Avoid taking antacids that contain aluminum or magnesium within 2 hours of taking this medication.

Special Instructions for Liquid (Suspension) Formulation

If you have difficulty swallowing pills, your doctor or pharmacist can help you prepare a liquid (suspension) formulation. If a liquid formulation is prepared:

Shake the liquid well before using it.
Measure your liquid dose carefully using the measuring device provided with the medication. If you don't have one, ask your pharmacist for a device to measure your medication accurately.
Do not use a household teaspoon or tablespoon to measure your medication, as this can lead to an incorrect dose.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom.
If you have a liquid (suspension) formulation, store it at room temperature.
If you prepared a liquid formulation from tablets, discard any unused portion after 3 months.

What to Do If You Miss a Dose

If you miss a dose, skip it and take your next dose at the usual time.
* Do not take two doses at the same time or take extra doses to make up for the missed dose.
💡

Lifestyle & Tips

  • Take sotalol on an empty stomach, at least 1 hour before or 2 hours after meals. Avoid taking with dairy products.
  • Do not stop taking sotalol suddenly, as this can worsen your heart condition. Your doctor will tell you how to slowly reduce the dose if needed.
  • Avoid grapefruit juice as it may affect absorption.
  • Report any signs of low potassium or magnesium (e.g., muscle weakness, cramps) as these can increase the risk of serious side effects.
  • Avoid activities that require alertness until you know how the medication affects you, as it can cause dizziness or lightheadedness.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For AFib/AFL: Initial 80 mg orally twice daily. For life-threatening VT/VF: Initial 80 mg orally twice daily or three times daily.
Dose Range: 80 - 640 mg

Condition-Specific Dosing:

Atrial Fibrillation/Flutter (AFib/AFL): Initial 80 mg orally twice daily. May increase to 120 mg twice daily, then 160 mg twice daily, allowing 3 days between increments. Max 160 mg twice daily for AFib/AFL. Doses >160 mg twice daily do not increase efficacy and increase risk of TdP.
Life-threatening Ventricular Arrhythmias (VT/VF): Initial 80 mg orally twice daily or three times daily. May increase to 160 mg twice daily or three times daily, allowing 2-3 days between increments. Max 640 mg/day (divided doses).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for most indications; limited data for supraventricular and ventricular arrhythmias, highly individualized dosing based on body surface area or weight, with careful monitoring.
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: CrCl 40-60 mL/min: Administer once daily (for AFib/AFL) or every 24 hours (for VT/VF).
Moderate: CrCl 20-39 mL/min: Administer every 36-48 hours (for AFib/AFL) or every 36-48 hours (for VT/VF).
Severe: CrCl < 20 mL/min: Not recommended due to significant accumulation and increased risk of proarrhythmia.
Dialysis: Sotalol is hemodialyzable. Dosing should be highly individualized and administered after dialysis, with careful monitoring.

Hepatic Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed

Pharmacology

đŸ”Ŧ

Mechanism of Action

Sotalol is a non-selective beta-adrenergic receptor blocker (Class II antiarrhythmic activity) and a potassium channel blocker (Class III antiarrhythmic activity). It prolongs the cardiac action potential duration and refractoriness in all cardiac tissues by blocking potassium channels, and it also reduces heart rate and myocardial contractility by blocking beta-adrenergic receptors.
📊

Pharmacokinetics

Absorption:

Bioavailability: 90-100%
Tmax: 2.5-4 hours
FoodEffect: Absorption is reduced by approximately 20% when taken with food, especially dairy products. Should be taken on an empty stomach.

Distribution:

Vd: 1.2-2.4 L/kg
ProteinBinding: <1%
CnssPenetration: Limited

Elimination:

HalfLife: 10-20 hours (prolonged in renal impairment)
Clearance: Primarily renal clearance
ExcretionRoute: Renal (urine)
Unchanged: 80-90%
âąī¸

Pharmacodynamics

OnsetOfAction: Within 2-3 hours
PeakEffect: 2.5-4 hours
DurationOfAction: 12-24 hours (dose-dependent)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Sotalol can cause dose-related prolongation of the QT interval, which is a marker for the potential for Torsade de Pointes (TdP) type of proarrhythmia. The risk of TdP is increased with higher doses, renal impairment, and hypokalemia/hypomagnesemia. Initiation of sotalol and dose increases must be done in a hospital setting with continuous ECG monitoring for at least 3 days or until steady-state QTc is achieved and stable.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Severe dizziness or fainting
Chest pain or pressure
Abnormal heartbeat, including fast or slow heartbeat, or a new or worsening irregular heartbeat
Excessive sweating
Changes in vision
Erectile dysfunction

If you have a history of heart disease, inform your doctor. Be aware that this medication can cause heart failure or worsen existing heart failure. If you experience any of the following symptoms, seek medical attention immediately:

Shortness of breath
Sudden weight gain
Abnormal heartbeat
New or worsening swelling in the arms or legs

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Dizziness, fatigue, or weakness
Headache
Diarrhea, nausea, or vomiting

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or lightheadedness
  • Fainting (syncope)
  • New or worsening palpitations (feeling your heart race or skip beats)
  • Shortness of breath
  • Chest pain
  • Swelling in your ankles or feet
  • Unusual fatigue or weakness
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Asthma or other respiratory problems that cause shortness of breath or wheezing
+ Heart failure (a weak heart)
+ Abnormal heart rhythms, including heart block or sick sinus syndrome
+ A slow heartbeat
Low levels of potassium or magnesium in your blood
If you are taking medications for an irregular heartbeat
If you are taking any medications that can cause a prolonged QT interval, a type of abnormal heartbeat. There are many medications that can cause this condition, so ask your doctor or pharmacist if you are unsure.

Additionally, if you are breast-feeding, please note that you should not breast-feed while taking this medication.

To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of all your medications, including:
Prescription and over-the-counter (OTC) medications
Natural products
Vitamins

Share information about all your health problems with your doctor and pharmacist to verify that it is safe to take this medication with your existing conditions. Never start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and be cautious when climbing stairs.

Monitoring Your Condition
Follow your doctor's instructions for checking your blood pressure and heart rate. Additionally, have blood work done as directed by your doctor, and discuss the results with them. An electrocardiogram (ECG) is required before starting this medication and during treatment; consult with your doctor about this.

Interference with Lab Tests
This medication may affect certain laboratory tests. Inform all your healthcare providers and lab personnel that you are taking this medication.

Risk of Low Blood Sugar
This medication may mask symptoms of low blood sugar, such as a rapid heartbeat, which can increase the risk of severe or prolonged low blood sugar. This risk is higher in people with diabetes, children, and those who are fasting, including individuals undergoing surgery, experiencing abnormal eating patterns, or vomiting. If you have questions or concerns, discuss them with your doctor.

Diabetes Management
If you have high blood sugar (diabetes), it is crucial to monitor your blood sugar levels closely while taking this medication. Inform your doctor if you experience fluid loss, excessive sweating, vomiting, diarrhea, decreased appetite, or unusual thirst.

Stopping the Medication
Do not stop taking this medication abruptly, as this can lead to worsened chest pain and, in some cases, heart attack. The risk is greater if you have certain types of heart disease. To avoid side effects, your doctor will guide you on how to gradually stop taking this medication. If you experience new or worsening chest pain or other heart problems, contact your doctor immediately.

Overactive Thyroid
This medication may make it more challenging to recognize symptoms of an overactive thyroid, such as a rapid heartbeat. If you have an overactive thyroid and stop taking this medication suddenly, your condition may worsen and become life-threatening. Consult with your doctor about this risk.

Allergic Reactions
If you have a history of severe allergic reactions, discuss this with your doctor, as you may be at risk of an even more severe reaction if you are exposed to the allergen again. If you use epinephrine to treat severe allergic reactions, inform your doctor, as epinephrine may be less effective while taking this medication.

Gender-Specific Risks
Female patients may have a higher risk of side effects; discuss this with your doctor.

Pregnancy and Breastfeeding
If you are pregnant or plan to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy.
🆘

Overdose Information

Overdose Symptoms:

  • Severe bradycardia (very slow heart rate)
  • Hypotension (low blood pressure)
  • Bronchospasm (difficulty breathing)
  • Hypoglycemia (low blood sugar)
  • Cardiogenic shock
  • Asystole (cardiac arrest)
  • Torsade de Pointes

What to Do:

Seek immediate medical attention or call 911. For suspected overdose, contact a poison control center (1-800-222-1222). Management is supportive and may include atropine for bradycardia, isoproterenol, dopamine, dobutamine, glucagon, or transvenous pacing. For TdP, IV magnesium, overdrive pacing, or defibrillation may be necessary.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Class Ia antiarrhythmics (e.g., disopyramide, quinidine, procainamide)
  • Class III antiarrhythmics (e.g., amiodarone, dofetilide, dronedarone)
  • Other drugs that prolong the QT interval (e.g., phenothiazines, tricyclic antidepressants, macrolide antibiotics, fluoroquinolones, certain antifungals, cisapride, bepridil)
  • Drugs that cause hypokalemia or hypomagnesemia (e.g., loop diuretics, thiazide diuretics, laxatives, amphotericin B) unless electrolyte imbalance is corrected
🔴

Major Interactions

  • Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem) - risk of severe bradycardia, AV block, hypotension
  • Digoxin - additive bradycardia, increased digoxin levels
  • Other beta-blockers - additive beta-blockade effects (bradycardia, hypotension)
  • Insulin and oral hypoglycemics - masking of hypoglycemia symptoms (tachycardia, tremors)
  • Clonidine - risk of rebound hypertension upon clonidine withdrawal if sotalol is not tapered first
🟡

Moderate Interactions

  • Alpha-1 blockers (e.g., prazosin) - increased risk of first-dose hypotension
  • NSAIDs - may reduce antihypertensive effect of sotalol
  • Cimetidine - may increase sotalol bioavailability
  • Aluminum/magnesium-containing antacids - may reduce sotalol absorption
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Electrocardiogram (ECG)

Rationale: To assess baseline QTc interval, heart rate, and rhythm. QTc must be <450 ms (or <500 ms in patients with bundle branch block) before initiation.

Timing: Prior to first dose and before each dose increase.

Serum Potassium (K+)

Rationale: Hypokalemia increases the risk of Torsade de Pointes. Must be corrected to >4 mEq/L.

Timing: Prior to first dose and before each dose increase.

Serum Magnesium (Mg2+)

Rationale: Hypomagnesemia increases the risk of Torsade de Pointes. Must be corrected.

Timing: Prior to first dose and before each dose increase.

Renal Function (CrCl)

Rationale: Sotalol is primarily renally eliminated; renal impairment necessitates dose adjustment.

Timing: Prior to first dose.

Heart Rate and Blood Pressure

Rationale: To assess baseline cardiovascular status and monitor for excessive bradycardia or hypotension.

Timing: Prior to first dose.

📊

Routine Monitoring

Electrocardiogram (ECG) - QTc interval

Frequency: At least every 8-12 hours for the first 2-3 days of initiation or dose escalation (in-hospital monitoring). Periodically thereafter.

Target: <500 ms (absolute QTc)

Action Threshold: Discontinue if QTc >500 ms (or >520 ms in patients with bundle branch block) or if new proarrhythmia occurs.

Serum Potassium (K+)

Frequency: Periodically, especially if on diuretics or with GI losses.

Target: >4 mEq/L

Action Threshold: Correct hypokalemia immediately.

Serum Magnesium (Mg2+)

Frequency: Periodically, especially if on diuretics or with GI losses.

Target: Normal range

Action Threshold: Correct hypomagnesemia immediately.

Renal Function (CrCl)

Frequency: Periodically, especially in elderly or those with changing renal status.

Target: Not applicable

Action Threshold: Adjust dose if CrCl declines.

Heart Rate and Blood Pressure

Frequency: Regularly, especially during dose titration.

Target: HR >50 bpm, BP within patient's normal range

Action Threshold: Reduce dose or discontinue if severe bradycardia (<50 bpm) or symptomatic hypotension occurs.

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Syncope (fainting)
  • Palpitations (new or worsening)
  • Shortness of breath
  • Chest pain
  • Fatigue
  • Swelling of ankles/feet

Special Patient Groups

🤰

Pregnancy

Sotalol is Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Sotalol crosses the placenta.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for fetal bradycardia and growth restriction.
Second Trimester: Potential for fetal bradycardia, hypoglycemia, and growth restriction.
Third Trimester: Potential for fetal bradycardia, hypoglycemia, and respiratory depression at birth. Neonates should be monitored for signs of beta-blockade for several days after birth.
🤱

Lactation

Sotalol is excreted into breast milk. The American Academy of Pediatrics considers sotalol to be compatible with breastfeeding, but caution is advised. Monitor breastfed infants for signs of beta-blockade (e.g., bradycardia, hypoglycemia).

Infant Risk: Low to Moderate (L3 - Moderately Safe). Potential for bradycardia, hypoglycemia, and respiratory depression in the infant, especially with high maternal doses or in premature infants.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established for most pediatric indications. Use in children is generally off-label and requires highly individualized dosing and close monitoring due to varying pharmacokinetics and increased sensitivity to adverse effects.

👴

Geriatric Use

Elderly patients are at increased risk of adverse effects, particularly proarrhythmia, due to age-related decline in renal function. Dose adjustments based on creatinine clearance are crucial. Initiate with lower doses and titrate slowly with careful monitoring.

Clinical Information

💎

Clinical Pearls

  • Initiation and dose escalation of sotalol (Betapace AF and Sorine) for AFib/AFL must occur in a hospital setting with continuous ECG monitoring for at least 3 days to assess QTc prolongation and risk of Torsade de Pointes.
  • Correct hypokalemia and hypomagnesemia prior to and during sotalol therapy to minimize the risk of proarrhythmia.
  • Sotalol should be taken on an empty stomach (at least 1 hour before or 2 hours after meals) to ensure consistent absorption.
  • Do not abruptly discontinue sotalol, especially in patients with ischemic heart disease, as it can exacerbate angina or precipitate myocardial infarction.
  • Regular monitoring of QTc interval, serum electrolytes (K+, Mg2+), heart rate, blood pressure, and renal function is essential throughout therapy.
  • Patients should be educated on symptoms of proarrhythmia (e.g., syncope, severe dizziness, palpitations) and instructed to seek immediate medical attention if they occur.
🔄

Alternative Therapies

  • Other Class III antiarrhythmics (e.g., amiodarone, dofetilide, dronedarone)
  • Other beta-blockers (e.g., metoprolol, carvedilol, atenolol) for rate control or other indications
  • Calcium channel blockers (e.g., diltiazem, verapamil) for rate control
  • Digoxin for rate control
  • Catheter ablation procedures
  • Cardioversion
💰

Cost & Coverage

Average Cost: $15 - $50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet; consult your pharmacist for more information. If you have any questions or concerns about this medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the substance taken, the amount, and the time it occurred.